S&P 500   2,998.30 (+0.01%)
DOW   26,993.67 (-0.12%)
QQQ   193.42 (+0.01%)
AAPL   235.89 (+0.67%)
FB   190.50 (+0.44%)
MSFT   139.54 (+0.05%)
GOOGL   1,252.87 (-0.08%)
CGC   20.73 (+2.07%)
NVDA   194.10 (+0.78%)
MU   44.61 (-1.85%)
BABA   174.08 (-1.22%)
GE   9.04 (-0.33%)
TSLA   261.18 (-0.48%)
AMD   31.25 (+0.74%)
T   38.09 (+0.82%)
F   9.19 (+0.99%)
PRI   124.23 (+0.22%)
NFLX   285.75 (-2.59%)
BAC   30.36 (+0.96%)
GILD   65.13 (-0.05%)
DIS   132.87 (+0.01%)
S&P 500   2,998.30 (+0.01%)
DOW   26,993.67 (-0.12%)
QQQ   193.42 (+0.01%)
AAPL   235.89 (+0.67%)
FB   190.50 (+0.44%)
MSFT   139.54 (+0.05%)
GOOGL   1,252.87 (-0.08%)
CGC   20.73 (+2.07%)
NVDA   194.10 (+0.78%)
MU   44.61 (-1.85%)
BABA   174.08 (-1.22%)
GE   9.04 (-0.33%)
TSLA   261.18 (-0.48%)
AMD   31.25 (+0.74%)
T   38.09 (+0.82%)
F   9.19 (+0.99%)
PRI   124.23 (+0.22%)
NFLX   285.75 (-2.59%)
BAC   30.36 (+0.96%)
GILD   65.13 (-0.05%)
DIS   132.87 (+0.01%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Meridian BioscienceOxford Immunotec GlobalHeskaQuotient
SymbolNASDAQ:VIVONASDAQ:OXFDNASDAQ:HSKANASDAQ:QTNT
Price Information
Current Price$9.97$15.53$76.85$8.83
52 Week RangeHoldBuyHoldBuy
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuy
Consensus Price Target$11.33$20.00$76.67$13.50
% Upside from Price Target13.67% upside28.82% upside-0.24% downside52.89% upside
Trade Information
Market Cap$423.27 million$420.97 million$576.32 million$505.64 million
Beta0.380.431.040.99
Average Volume340,204267,03797,424238,409
Sales & Book Value
Annual Revenue$213.57 million$59.75 million$127.45 million$29.13 million
Price / Sales1.996.974.7020.09
Cashflow$0.96 per share$0.66 per share$2.16 per shareN/A
Price / Cash10.4023.4635.60N/A
Book Value$4.14 per share$8.12 per share$16.13 per share$0.03 per share
Price / Book2.411.914.76294.33
Profitability
Net Income$23.84 million$120.78 million$5.85 million$-105,390,000.00
EPS$0.74$0.51$1.42($1.92)
Trailing P/E Ratio13.4730.4454.12N/A
Forward P/E Ratio19.55N/A640.42N/A
P/E GrowthN/AN/AN/AN/A
Net Margins12.65%208.48%1.93%-352.75%
Return on Equity (ROE)17.82%14.76%6.35%N/A
Return on Assets (ROA)11.97%12.58%4.85%-57.94%
Dividend
Annual PayoutN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.40%0.03%0.04%72.27%
Current Ratio6.93%13.35%3.93%5.17%
Quick Ratio4.75%12.76%2.05%4.42%
Ownership Information
Institutional Ownership Percentage88.58%94.09%89.08%70.56%
Insider Ownership Percentage2.00%4.21%14.00%14.20%
Miscellaneous
Employees585215347N/A
Shares Outstanding42.71 million26.83 million7.80 million66.27 million
Next Earnings Date11/7/2019 (Confirmed)11/8/2019 (Estimated)11/5/2019 (Confirmed)11/4/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionable
 Meridian BioscienceOxford Immunotec GlobalHeskaQuotient

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel